Antimicrobial synergism and antibiofilm activities of amoxicillin loaded citric acid-magnesium ferrite nanocomposite: Effect of UV-illumination, and membrane leakage reaction mechanism

Trends of biomolecule-conjugated nanoparticles as antibiofilm

Biofilm is a powerful barrier that significantly enhances the pathogenicity of bacteria and the development of multidrug resistance. Nanoparticles (NPs) coupled with biomolecules provide a novel approach to addressing this issue. This review briefly discusses the current trends in Biomolecule-Conjugated NPs combined with enzymes, antibiotics, biosurfactants, and natural bioactive compounds as antibiofilm agents emphasizing their superior antibiofilm activity. This conjugation enhances bioavailability, lowers toxicity, requires smaller dosage, and reduces complications caused by infections associated with biofilms. These conjugated systems offer an avenue for industrial, ecological, and medical applications. By increasing the variety of these conjugation techniques, innovative approaches to biofilm-related problems will become possible, with significant advantages for healthcare and other fields.

Understanding antimicrobial activity of biogenic selenium nanoparticles and selenium/chitosan nano-incorporates via studying their inhibition activity against key metabolic enzymes

Microbial metabolic enzymes play a crucial role in several biological processes that have a significant impact on growth and proliferation. Therefore, inhibiting specific key metabolic enzymes can be an applicable approach for developing antimicrobial agents that selectively target pathogens. In the current study, selenium nanoparticles (Se NPs) extracellularly biosynthesized by Nocardiopsis sp. MAR13 and Se NPs incorporated with nano-chitosan (NCh) (Se/Ch-nano-incorporate) were evaluated for their antimicrobial activity against various microbial pathogens such as Salmonella typhi, Proteus vulgaris, Staphylococcus aureus, Escherichia coli, Aspergillus flavus, Aspergillus niger, Rhizoctonia sp., Candida albicans ATCC10231. The synthesized Se NPs, and Se/Ch-nano-incorporate were characterized by UV-Vis., FTIR, HRTEM, SEM, EDX, DLS, Zeta potential, and XRD. Additionally, their inhibition activity against microbial metabolic key enzymes, including phosphoglucose isomerase (PGI), pyruvate dehydrogenase (PDH), glucose-6-phosphate dehydrogenase (G6PDH), and nitrate reductase (NR), was assessed. The impact on protein leakage from bacterial cell membranes was also evaluated as a potential mechanism of antimicrobial action. On the other hand, MCF-7 and A549 tumor cell lines, as well as WI-38 normal cell lines, were used to assess their cytotoxic activity. It was found that Se NPs were spherical with a diameter range of 60.2 to 120.2 nm. In contrast, Se/Ch-nano-incorporate had a roughly spherical shape with a diameter range of 21.4 to 32.7 nm and substantially higher stability. Both synthesized agents exhibited strong antimicrobial activity against the most tested microbial pathogens with substantial inhibitory effect on the tested enzymes and notable protein leakage. Furthermore, they showed potent anticancer activity against both tumor cell lines with low cytotoxicity against WI-38 normal cell line. Consequently, Se NPs and Se/Ch-nano-incorporate are highly recommended to be employed as antimicrobial and anticancer agents with promised biosafety, eco-friendliness, and efficacy.

Unveiling the photocatalytic and antimicrobial activities of star-shaped gold nanoparticles under visible spectrum

This study reports on the facile development of star-shaped gold nanoparticles via seed-mediated growth protocol. Gold nanostars (AuNSTs) demonstrated average particle size of 48 nm using transmission electron microscopy (TEM). Chemical composition of AuNSTs was verifired using energy dispersive X-ray spectroscopy (EDX) mapping. AuNSTs demonstrated high optical response under visible spectrum, with maximum absorption at 685 nm, using UV-Vis spectroscopy. Therefore AuNSTs could be involoved into photocatalytic reaction under visible spectrum. AuNSTs demonstrated superior performance in degradation of rhodamine B dye (RB), and disinfection of some pathogenic bacteria. AuNSTs offered enhanced removal efficiency against rhodamine B dye (82.0 ± 0.35% in 135 min) under visible irradiation. Remarkably, under proper conditions of pH = 9, approximately 94 ± 0.55% of a 10 ppm RB solution was effectively photodegraded after 135 min; this could be ascribed to the strong electrostatic attraction between negatively charged AuNSTs surface and positive RB contaminant. This superior photocatalytic activity of AuNSTs could be correlated to high interfacial charge transfer efficiency for Au, and enhanced charge pair separation under visible spectrum. Additionally, AuNSTs exhibited potential antibacterial activity against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). AuNSTs demonstrated substantial antibacterial activity via disk diffusion and microbroth dilution tests with zones of inhibition and minimum inhibitory concentrations (MIC) for E. coli (20.0 ± 0.54 mm, 1.25 µg/ml) and S. aureus (23.0 ± 0.35 mm, 0.625 µg/ml), respectively. In conclusion, AuNSTs demonstrated efficient dye removal capabilities along with significant antimicrobial activity against gram-positive and gram-negative bacterial strains.

Long-Circulating Nanoemulsion with Oxygen and Drug Co-Delivery for Potent Photodynamic/Antibiotic Therapy Against Multidrug-Resistant Gram-Negative Bacterial Infection

Purpose

Compared to conventional photodynamic therapy (PDT), oxygen-affording PDT represents a promising strategy for treating multidrug-resistant (MDR) gram-negative bacterial infections due to its enhanced sensitization ability towards bacteria and amplified therapeutic efficacy. Over the last decade, various nanoplatforms for the co-delivery of oxygen and photosensitizers have been developed. However, their application in the treatment of infectious diseases is hampered by their poor stability and easy clearance by the reticuloendothelial system (RES).

Methods

To address these obstacles, we reported an erythrocyte membrane (EM) camouflaged nanoemulsion containing chlorin e6 (Ce6) and perfluorocarbon (FDC), named ECF, showing good colloidal stability and long-circulating potential, making it suitable for fighting against MDR Gram-negative bacterial infections. The nanoemulsion was fabricated and characterized. The oxygen loading and release performance, photodynamic activity, and bactericidal performance of ECF against Acinetobacter baumannii (A. baumannii) were evaluated. Furthermore, the antiphagocytosis profile was tested in vitro using Raw 264.7 cells. In addition, the pharmacokinetic behavior and therapeutic efficiency of ECF were studied in vivo.

Results

ECF exhibited superior oxygen loading and release behavior, potent photodynamic activity, and negligible toxicity to mammalian cells. Upon light irradiation, the antibacterial rate of preoxygenated-ECF reached 98% at 40 μg mL-1 of Ce6 and the bactericidal activity of preoxygenated-ECF and Gen was 3.3 folds higher than that of Gen. Furthermore, ECF could effectively inhibit uptake by phagocytes and circulate in the blood 1.5-fold longer than that of nanoemulsion without EM modification (CF) following intravenous administration. In addition, preoxygenated-ECF combined with antibiotic plus light irradiation showed prominent therapeutic efficacy in treating A. baumannii-induced acute peritonitis, accompanied by good biocompatibility in vivo.

Conclusion

Our results provide a novel paradigm for evading immune clearance, prolonging retention time and improving synergetic bactericidal capacity in combination with PDT and antibiotic therapy against planktonic bacteria and gram-negative bacterial infections.

Development of novel reduced graphene oxide/metalloporphyrin nanocomposite with photocatalytic and antimicrobial activity for potential wastewater treatment and medical applications

This research investigates a novel nanocomposite material composed of reduced graphene oxide (rGO) and nickel-5,15-bisdodecylporphyrin (Ni-BDP) nanoparticles for the effective removal of methyl orange (MO), a harmful synthetic dye, from water. The structure and composition of the synthesized rGO/Ni-BDP nanocomposite were characterized using high-resolution transmission electron microscopy (HR-TEM), Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and ultraviolet-visible (UV-Vis) spectroscopy. The study demonstrates the material's efficacy as both a catalyst and adsorbent for MO removal. Optimal performance was observed at pH 3.0, where the positively charged nanocomposite surface facilitated strong interactions with negatively charged MO molecules, leading to enhanced photocatalytic activity. Under these conditions, 0.01 g of the nanocomposite achieved an impressive 86.2% MO removal efficiency. Furthermore, the study explored the reusability of the rGO/Ni-BDP nanocomposite in repeated cycles of photocatalytic MO degradation under visible light irradiation. While exhibiting some decrease in efficiency over five cycles, the nanocomposite maintained a respectable degradation rate even after multiple uses. Finally, the antimicrobial properties of the nanocomposite were evaluated against both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria exhibiting a zone of inhibition measuring 23 mm and 26, respectively. The minimum inhibitory concentration (MIC) values of 2.50 µg/ml and 1.25 µg/ml for Escherichia coli and Staphylococcus aureus, respectively. The results revealed significant antibacterial activity, demonstrating the broad-spectrum efficacy of the rGO/Ni-BDP nanocomposite. This research underscores the potential of the rGO/Ni-BDP nanocomposite as a versatile material for environmental remediation and antibacterial applications.

Nanoformulations for dismantling fungal biofilms: The latest arsenals of antifungal therapy

Globally, fungal infections have evolved as a strenuous challenge for clinicians, particularly in patients with compromised immunity in intensive care units. Fungal co-infection in Covid-19 patients has made the situation more formidable for healthcare practitioners. Surface adhered fungal population known as biofilm often develop at the diseased site to elicit antifungal tolerance and recalcitrant traits. Thus, an innovative strategy is required to impede/eradicate developed biofilm and avoid the formation of new colonies. The development of nanocomposite-based antibiofilm solutions is the most appropriate way to withstand and dismantle biofilm structures. Nanocomposites can be utilized as a drug delivery medium and for fabrication of anti-biofilm surfaces capable to resist fungal colonization. In this context, the present review comprehensively described different forms of nanocomposites and mode of their action against fungal biofilms. Amongst various nanocomposites, efficacy of metal/organic nanoparticles and nanofibers are particularly emphasized to highlight their role in the pursuit of antibiofilm strategies. Further, the inevitable concern of nanotoxicology has also been introduced and discussed with the exigent need of addressing it while developing nano-based therapies. Further, a list of FDA-approved nano-based antifungal formulations for therapeutic usage available to date has been described. Collectively, the review highlights the potential, scope, and future of nanocomposite-based antibiofilm therapeutics to address the fungal biofilm management issue.

Chitinase-functionalized UiO-66 framework nanoparticles active against multidrug-resistant Candida Auris

Candida auris (C. auris) is a yeast that has caused several outbreaks in the last decade. Cell wall chitin plays a primary role in the antifungal resistance of C. auris. Herein, we investigated the potential of chitinase immobilized with UiO-66 to act as a potent antifungal agent against C. auris. Chitinase was produced from Talaromyces varians SSW3 in a yield of 8.97 U/g dry substrate (ds). The yield was statistically enhanced to 120.41 U/g ds by using Plackett-Burman and Box-Behnken design. We synthesized a UiO-66 framework that was characterized by SEM, TEM, XRD, FTIR, a particle size analyzer, and a zeta sizer. The produced framework had a size of 70.42 ± 8.43 nm with a uniform cubic shape and smooth surface. The produced chitinase was immobilized on UiO-66 with an immobilization yield of 65% achieved after a 6 h loading period. The immobilization of UiO-66 increased the enzyme activity and stability, as indicated by the obtained Kd and T1/2 values. Furthermore, the hydrolytic activity of chitinase was enhanced after immobilization on UiO-66, with an increase in the Vmax and a decrease in the Km of 2- and 38-fold, respectively. Interestingly, the antifungal activity of the produced chitinase was boosted against C. auris by loading the enzyme on UiO-66, with an MIC50 of 0.89 ± 0.056 U/mL, compared to 5.582 ± 0.57 U/mL for the free enzyme. This study offers a novel promising alternative approach to combat the new emerging pathogen C. auris.

Enhanced anticancer activity of silver doped zinc oxide magnetic nanocarrier loaded with sorafenib for hepatocellular carcinoma treatment

Drug delivery is the process or method of delivering a pharmacological product to have therapeutic effects on humans or animals. The use of nanoparticles to deliver medications to cells is driving the present surge in interest in improving human health. Green nanodrug delivery methods are based on chemical processes that are acceptable for the environment or that use natural biomaterials such as plant extracts and microorganisms. In this study, zinc oxide-superparamagnetic iron oxide-silver nanocomposite was synthesized via green synthesis method using Fusarium oxysporum fungi mycelia then loaded with sorafenib drug. The synthesized nanocomposites were characterized by UV-visibile spectroscopy, FTIR, TEM and SEM techniques. Sorafenib is a cancer treatment and is also known by its brand name, Nexavar. Sorafenib is the only systemic medication available in the world to treat hepatocellular carcinoma. Sorafenib, like many other chemotherapeutics, has side effects that restrict its effectiveness, including toxicity, nausea, mucositis, hypertension, alopecia, and hand-foot skin reaction. In our study, 40 male albino rats were given a single dose of diethyl nitrosamine (DEN) 60 mg/kg b.wt., followed by carbon tetrachloride 2 ml/kg b.wt. twice a week for one month. The aim of our study is using the zinc oxide-superparamagnetic iron oxide-silver nanocomposite that was synthesized by Fusarium oxysporum fungi mycelia as nanocarrier for enhancement the sorafenib anticancer effect.

In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa

BACKGROUND

Addressing microbial resistance urgently calls for alternative treatment options. This study investigates the impact of a bimetallic formulation containing colistin, silver, and copper oxide on a pandrug-resistant, highly virulent Pseudomonas aeruginosa (P. aeruginosa) isolate from a cancer patient at the National Cancer Institute, Cairo University, Egypt.

METHODS

Silver nanoparticles (Ag NPs), copper oxide nanoparticles (CuO NPs), and bimetallic silver-copper oxide nanoparticles (Ag-CuO NPs) were synthesized using gamma rays, combined with colistin (Col), and characterized by various analytical methods. The antimicrobial activity of Col-Ag NPs, Col-CuO NPs, and bimetallic Col-Ag-CuO NPs against P. aeruginosa was evaluated using the agar well diffusion method, and their minimum inhibitory concentration (MIC) was determined using broth microdilution. Virulence factors such as pyocyanin production, swarming motility, and biofilm formation were assessed before and after treatment with bimetallic Col-Ag-CuO NPs. The in vivo efficacy was evaluated using the Galleria mellonella model, and antibacterial mechanism were examined through membrane leakage assay.

RESULTS

The optimal synthesis of Ag NPs occurred at a gamma ray dose of 15.0 kGy, with the highest optical density (OD) of 2.4 at 375 nm. Similarly, CuO NPs had an optimal dose of 15.0 kGy, with an OD of 1.5 at 330 nm. Bimetallic Ag-CuO NPs were most potent at 15.0 kGy, yielding an OD of 1.9 at 425 nm. The MIC of colistin was significantly reduced when combined with nanoparticles: 8 µg/mL for colistin alone, 0.046 µg/mL for Col-Ag NPs, and 0.0117 µg/mL for Col-Ag-CuO NPs. Bimetallic Col-Ag-CuO NPs reduced the MIC four-fold compared to Col-Ag NPs. Increasing the sub-inhibitory concentration of bimetallic nanoparticles from 0.29 × 10-2 to 0.58 × 10-2 µg/mL reduced P. aeruginosa swarming by 32-64% and twitching motility by 34-97%. At these concentrations, pyocyanin production decreased by 39-58%, and biofilm formation was inhibited by 33-48%. The nanoparticles were non-toxic to Galleria mellonella, showing 100% survival by day 3, similar to the saline-treated group.

CONCLUSIONS

The synthesis of bimetallic Ag-CuO NPs conjugated with colistin presents a promising alternative treatment for combating the challenging P. aeruginosa pathogen in hospital settings. Further research is needed to explore and elucidate the mechanisms underlying the inhibitory effects of colistin-bimetallic Ag-CuO NPs on microbial persistence and dissemination.

Photocatalytic, antimicrobial and antibiofilm activities of MgFe2O4 magnetic nanoparticles

This study reports the antibacterial and antibiofilm activities of Magnesium ferrite nanoparticles (MgFe2O4) against gram-positive and gram-negative bacteria. The photocatalytic degradation of Carbol Fuchsin (CF) dye (a class of dyestuffs that are resistant to biodegradation) under the influence of UV-light irradiation is also studied. The crystalline magnesium ferrite (MgFe2O4) nanoparticles were synthesized using the co-precipitation method. The morphology of the resulting nanocomposite was examined using scanning electron microscopy (SEM), while transmission electron microscopy (TEM) was employed for further characterization of particle morphology and size. Fourier transform infrared (FTIR) spectroscopy and X-ray diffraction (XRD) were utilized to analyze the crystalline structure, chemical composition, and surface area, respectively. Optical properties were evaluated using UV-Vis spectroscopy. The UV-assisted photocatalytic performance of MgFe2O4 nanoparticles was assessed by studying the decolorization of Carbol fuchsin (CF) azo dye. The crystallite size of the MgFe2O4 nanoparticles at the (311) plane, the most prominent peak, was determined to be 28.5 nm. The photocatalytic degradation of 10 ppm CF using 15 mg of MgFe2O4 nanoparticles resulted in a significant 96% reduction after 135 min at ambient temperature (25 °C) and a pH value of 9. Additionally, MgFe2O4 nanoparticles exhibited potent antibacterial activity against E. coli and S. aureus in a dose dependent manner with maximum utilized concentration of 30 µg/ml. Specifically, MgFe2O4 nanoparticles demonstrated substantial antibacterial activity via disk diffusion and microbroth dilution tests with zones of inhibition and minimum inhibitory concentrations (MIC) for E. coli (26.0 mm, 1.25 µg/ml) and S. aureus (23.0 mm, 2.5 µg/ml), respectively. Moreover, 10.0 µg/ml of MgFe2O4 nanoparticles elicited marked percent reduction in biofilm formation by E. coli (89%) followed by S. aureus (78.5%) after treatment. In conclusion, MgFe2O4 nanoparticles demonstrated efficient dye removal capabilities along with significant antimicrobial and antibiofilm activity against gram-positive and gram-negative bacterial strains suggesting their potential as promising antimicrobial and detoxifying agents.

Pomegranate Peel Extract Stabilized Selenium Nanoparticles Synthesis: Promising Antimicrobial Potential, Antioxidant Activity, Biocompatibility, and Hemocompatibility

The green synthesis of selenium nanoparticles (Se NPs) had been synthesized by pomegranate peel extract (PPE). The antimicrobial, antioxidant, and anticancer activities of the synthesized Se NPs, as well as their hemocompatibility, were investigated. Se NPs were characterized by UV-Vis., SEM, XRD, HR-TEM, DLS, EDX, FTIR, and mapping techniques. HR-TEM image represented the spheroidal forms with moderately monodispersed NPs with a mean diameter 14.5 nm. The SEM image of Se NPs, incorporated with PPE, exhibits uniform NP surfaces, and the appearance was clear. The antimicrobial results confirmed the potential of Se NPs to hinder the growth of some tested pathogenic microbes. Results revealed that Se NPs exhibited promising antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, Staphylococcus aureus, and Streptococcus mutans where inhibition zones were 29, 16, 41, 22, and 54 mm, respectively. Likewise, it exhibited antifungal activity where the values of inhibition zones were 41, 40, 38, and 36 mm against Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, and A. niger, respectively. The antioxidant activities of Se NPs at concentrations 250-4000 µg/mL were greater than 90% in all cases. Se NP concentrations of 500 µg/mL or less are safe in usage according to hemocompatibility study. Se NPs had an IC50 of 113.73 µg/mL in a cytotoxicity experiment. Results revealed that Se NPs have promising anticancer activities against MCF7 and Mg63 cancerous cell line, where IC50 was 69.8 and 47.9 μg/mL, respectively. In conclusion, Se NPs were successfully biosynthesized using PPE for the first time; these Se NPs had promising antimicrobial, antioxidant, and anticancer activities.

Enhanced photocatalytic and antibacterial activities of novel Ag-HA bioceramic nanocatalyst for waste-water treatment

Hydroxyapatite (HA), the most common bioceramic material, offers attractive properties as a catalyst support. Highly crystalline mono-dispersed silver doped hydroxyapatite (Ag-HA) nanorods of 60 nm length was developed via hydrothermal processing. Silver dopant offered enhanced chemisorption for crystal violet (CV) contaminant. Silver was found to intensify negative charge on the catalyst surface; in this regard enhanced chemisorption of positively charged contaminants was accomplished. Silver dopant experienced decrease in the binding energy of valence electron for oxygen, calcium, and phosphorous using X-ray photoelectron spectroscopy XPS/ESCA; this finding could promote electron-hole generation and light absorption. Removal efficiency of Ag-HA nanocomposite for CV reached 88% after the synergistic effect with 1.0 mM H2O2; silver dopant could initiate H2O2 cleavage and intensify the release of active ȮH radicals. Whereas HA suffers from lack of microbial resistance; Ag-HA nanocomposite demonstrated high activity against Gram-positive (S. aureus) bacteria with zone of inhibition (ZOI) mm value of 18.0 mm, and high biofilm inhibition of 91.1%. Ag-HA nanocompsite experienced distinctive characerisitcs for utilization as green bioceramic photocatalyst for wastewater treatment.

Amygdalin-folic acid-nanoparticles inhibit the proliferation of breast cancer and enhance the effect of radiotherapy through the modulation of tumor-promoting factors/ immunosuppressive modulators in vitro

INTRODUCTION

Breast cancer (BC) cells often develop multiple mechanisms of chemo- and radio-resistance during tumor progression, which is the major reason for the failure of breast cancer therapy. Targeted nanomedicines have tremendous therapeutic potential in BC treatment over their free drug counterparts. Searching for chemo- and radio-sensitizers to overcome such resistance is therefore urgently required. The goal of this study is to evaluate and compare the radio-sensitizer efficacy of amygdalin-folic acid nanoparticles (Amy-F) on MCF-7 and MDA-MB-231 cells.

MATERIALS AND METHODS

The effects of Amy-F on MCF-7 and MDA-MB-231 cell proliferation and IC50 were assessed using MTT assay. The expression of proteins involved in several mechanisms induced by Amy-F in MCF-7 and MDA-MB-231 cells, including growth inhibition, apoptosis, tumor growth regulators, immuno-modulators, and radio-sensitizing activities were evaluated via flow cytometry and ELISA assay.

RESULTS

Nanoparticles demonstrated sustained Amy-F release properties and apparent selectivity towards BC cells. Cell-based assays revealed that Amy-F markedly suppresses cancer cell growth and improves radiotherapy (RT) through inducing cell cycle arrest (G1 and sub-G1), and increases apoptosis as well as reduces the proliferation of BC by down-regulating mitogen-activated protein kinases (MAPK/P38), iron level (Fe), nitric oxide (NO), and up-regulating the reactive oxygen species level (ROS). Amy-F has also been shown to suppress the expression of the cluster of differentiation (CD4 and CD80), and interfere with the Transforming growth factor beta (TGF- β)/Interferon-gamma (INF-g)/Interleukin-2 (IL-2)/Interleukin-6 (IL-6)/Vascular endothelial growth factor (VEGF) induced suppression in its signaling hub, while up-regulating natural killer group 2D receptor (NKG2D) and CD8 expression.

CONCLUSIONS

Collectively, the novel Amy-F either alone or in combination with RT abrogated BC proliferation.

Promising antimicrobial and antibiofilm activities of Orobanche aegyptiaca extract-mediated bimetallic silver-selenium nanoparticles synthesis: Effect of UV-exposure, bacterial membrane leakage reaction mechanism, and kinetic study

In this research, Orobanche aegyptiaca extract was utilized as an eco-friendly, and cost-effective green route for the construction of bimetallic silver-selenium nanoparticles (Ag-Se NPs). Bimetallic Ag-Se NPs were characterized by XRD, EDX, FTIR, HR-TEM, DLS, SEM/mapping and EDX studies. Antimicrobial, and antibiofilm potentials were tested against some selected pathogenic bacteria and unicellular fungi by ZOI, MIC, effect of UV exposure, and inhibition %. Reaction mechanism was assessed through membrane leakage assay and SEM imaging. HRTEM analysis confirmed the spherical nature and was ranged from 18.1 nm to 72.0 nm, and the avarage particle size is determined to be 30.58 nm. SEM imaging prove that bimetallic Ag-Se NPs presents as a bright particles, and both Ag and Se were distributed equally across O. aegyptiaca extract and Guar gum stabilizers. ZOI results showed that, bimetallic Ag-Se NPs have antimicrobial activity against S. aureus (20.0 nm), E. coli (18.5 nm), P. aeruginosa (12.6 nm), and C. albicans (18.2 nm). In addition, bimetallic Ag-Se NPs were able to inhibit the biofilm formation for S. aureus by 79.48%, for E. coli by 78.79%, for P. aeruginosa by 77.50%, and for C. albicans by 73.73%. Bimetallic Ag-Se NPs are an excellent disinfectant once it had excited by UV light. It was observed that the quantity of cellular protein discharged from S. aureus is directly proportional to the concentration of bimetallic Ag-Se NPs and found to be 244.21 μg/mL after the treatment with 1 mg/mL, which proves the antibacterial characteristics, and explains the creation of holes in the cell membrane of S. aureus producing in the oozing out of the proteins from the S. aureus cytoplasm. Based on the promising properties, they showed superior antimicrobial potential at low concentration (to avoid toxicity) and continued-phase durability, they may use in pharmaceutical and biomedical applications.

An Explorative Review on Advanced Approaches to Overcome Bacterial Resistance by Curbing Bacterial Biofilm Formation

The continuous emergence of multidrug-resistant pathogens evoked the development of innovative approaches targeting virulence factors unique to their pathogenic cascade. These approaches aimed to explore anti-virulence or anti-infective therapies. There are evident concerns regarding the bacterial ability to create a superstructure, the biofilm. Biofilm formation is a crucial virulence factor causing difficult-to-treat, localized, and systemic infections. The microenvironments of bacterial biofilm reduce the efficacy of antibiotics and evade the host's immunity. Producing a biofilm is not limited to a specific group of bacteria; however, Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus biofilms are exemplary models. This review discusses biofilm formation as a virulence factor and the link to antimicrobial resistance. In addition, it explores insights into innovative multi-targeted approaches and their physiological mechanisms to combat biofilms, including natural compounds, phages, antimicrobial photodynamic therapy (aPDT), CRISPR-Cas gene editing, and nano-mediated techniques.

Cefotaxime incorporated bimetallic silver-selenium nanoparticles: promising antimicrobial synergism, antibiofilm activity, and bacterial membrane leakage reaction mechanism

In this research, we reported for the first time the simple incorporation of antibiotic cefotaxime (CFM) with the synthesized Ag NPs, Se NPs, and bimetallic Ag-Se NPs by gamma rays, as a promising cost-effective, and eco-friendly method. The synthesized nanocomposites were characterized by UV-Vis. spectroscopy, XRD, EDX, HR-TEM, SEM/mapping, and EDX studies. The antimicrobial synergistic potential was investigated after CFM drug incorporation. Antibiofilm activity, growth curve assay, and effect of UV illumination were examined against some pathogenic microbes. The antibacterial reaction mechanism was evaluated by protein leakage assay and SEM imaging. HRTEM imaging confirmed the spherical shape and an average diameter of 10.95, 20.54, and 12.69 nm for Ag NPs, Se NPs, and Ag-Se NPs, respectively. Ag NPs-CFM, Se NPs-CFM, and Ag-Se NPs-CFM possessed antimicrobial activity against Staphylococcus aureus (40, 42, and 43 mm ZOI, respectively), Escherichia coli (33, 35, and 34 mm ZOI, respectively) and Candida albicans (25, 22, and 23 mm ZOI, respectively). CFM-incorporated Ag-Se NPs were able to inhibit biofilm formation of S. aureus (96.09%), E. coli (98.32%), and C. albicans (95.93%). Based on the promising results, the synthesized nanocomposites showed superior antimicrobial potential at low concentrations and continued-phase durability; they may find use in pharmaceutical, and biomedical applications.

Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections

Antimicrobial agents and alternative strategies to combat bacterial infections have become urgent due to the rapid development of multidrug-resistant bacteria caused by the misuse and overuse of antibiotics, as well as the ineffectiveness of antibiotics against difficult-to-treat infectious diseases. Nanobiotics is one of the strategies being explored to counter the increase in antibiotic-resistant bacteria. Nanobiotics are antibiotic molecules encapsulated in nanoparticles or artificially engineered pure antibiotics that are ≤ 100 nm in size in at least one dimension. Formulation scientists recognize nanobiotic delivery systems as an effective strategy to overcome the limitations associated with conventional antibiotic therapy. This review highlights the general mechanisms by which nanobiotics can be used to target resistant microbes and biofilm-associated infections. We focus on the design elements, properties, characterization, and toxicity assessment of organic nanoparticles, inorganic nanoparticle and molecularly imprinted polymer-based nano-formulations that can be designed to improve the efficacy of nanobiotic formulation.

Multifunctional nanocomposites DDMplusAF inhibit the proliferation and enhance the radiotherapy of breast cancer cells via modulating tumor-promoting factors and metabolic reprogramming

Background

Tumor-promoting factors (TPF) and metabolic reprogramming are hallmarks of cancer cell growth. This study is designed to combine the newly synthesized two nanocomposites DDM (HA-FA-2DG@DCA@MgO) and AF (HA-FA-Amygdaline@Fe2O3) with fractionated doses of radiotherapy (6 Gy-FDR; fractionated dose radiotherapy) to improve the efficiency of chemo-radiotherapy against breast cancer cell lines (BCCs; MCF-7 and MDA-MB-231). The physicochemical properties of each nanocomposite were confirmed using energy dispersive XRD, FTIR, HR-TEM, and SEM. The stability of DDMPlusAF was also examined, as well as its release and selective cellular uptake in response to acidic pH. A multiple-MTT assay was performed to evaluate the radiosensitivity of BCCs to DDMPlusAF at 3 Gy (single dose radiotherapy; SDR) and 6 Gy-FDR after 24, 48, and 72 h. Finally, the anti-cancer activity of DDMPlusAF with 6 Gy-FDR was investigated via assessing the cell cycle distribution and cell apoptosis by flow cytometry, the biochemical mediators (HIF-1α, TNF-α, IL-10, P53, PPAR-α, and PRMT-1), along with glycolytic pathway (glucose, HK, PDH, lactate, and ATP) as well as the signaling effectors (protein expression of AKT, AMPK, SIRT-1, TGF-β, PGC-1α, and gene expression of ERR-α) were determined in this study.

Results

The stability of DDMPlusAF was verified over 6 days without nanoparticle aggregation. DDMPlusAF release and selectivity data revealed that their release was amenable to the acidic pH of the cancer environment, and their selectivity was enhanced towards BCCs owing to CD44 and FR-α receptors-mediated uptake. After 24 h, DDMPlusAF boosted the BCC radiosensitivity to 6 Gy-FDR. Cell cycle arrest (G2/M and pre-G1), apoptosis induction, modulation of TPF mediators and signaling effectors, and suppression of aerobic glycolysis, all confirmed DDMPlusAF + 6 Gy’s anti-cancer activity.

Conclusions

It could be concluded that DDMPlusAF exerted a selective cancer radiosensitizing efficacy with targeted properties for TPF and metabolic reprogramming in BCCs therapy.

Potential Impact of Reduced Graphene Oxide Incorporated Metal Oxide Nanocomposites as Antimicrobial, and Antibiofilm Agents Against Pathogenic Microbes: Bacterial Protein Leakage Reaction Mechanism

In the current study, nanocomposites-based reduced graphene oxide (RGO) and metal oxides (AgO, NiO, and ZnO) were fabricated. The starting precursor and RGO were characterized by XRD, Raman, SEM, and HRTEM, while SEM and EDX mapping validated the synthesized nanocomposites. In addition, ZOI, MIC, antibiofilm, and growth curve were tested. The antimicrobial reaction mechanism was investigated by protein leakage assay and SEM imaging. Results revealed that all synthesized nanocomposites (RGO-AgO, RGO-NiO, and RGO-ZnO) have outstanding antimicrobial activity against pathogenic bacteria and unicellular fungi. Moreover, RGO-AgO, RGO-NiO, and RGO-ZnO nanocomposites exhibited an antibiofilm activity percentage against Staphylococcus aureus (91.72%), Candida albicans  (91.17%), and Escherichia coli (90.36%). The SEM analysis of S. aureus after RGO-AgO treatment indicated morphological differences, including the whole lysis of the outer surface supported by deformations of the bacterial cells. It was observed that the quantity of cellular protein leakage from S. aureus is directly proportional to the concentration of RGO-AgO, RGO-NiO, and RGO-ZnO nanocomposites and found to be 260.25 µg/mL, 110.55 µg/mL, and 99.90 µg/mL, respectively. The prepared nanocomposites promise to treat resistant microbes as a new strategy for managing infectious diseases.